Axoltis Pharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ALS Phase II Study of NX210c (NCT06365216) | Axoltis Pharma | 2024-10-25 |
| MAD Study of NX210c (NCT05827653) | Axoltis Pharma | 2022-12-05 |
Track Axoltis Pharma automatically
Every clearance here is in the API, with alerts when new ones post.